Stay updated on Fisogatinib in Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page
- Check7 days agoChange DetectedThe page footer now shows Revision: v3.6.4, replacing the previous v3.6.3. This indicates a software/template version update for the page without altering the study content.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3 on the page. This reflects a minor platform build update and does not modify study information or patient-facing content.SummaryDifference0.0%

- Check36 days agoChange DetectedRevision label on the page updated from v3.6.0 to v3.6.2, indicating a minor platform update. The page's study details and listed locations remain unchanged.SummaryDifference0.0%

- Check50 days agoChange DetectedRecruitment status now indicates recruitment is closed. The page adds help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment header formatting, along with a revision footer change from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check57 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a new version of the page. This appears to be a small maintenance update rather than changes to the study content.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, signaling a new version of the page.SummaryDifference0.0%

Stay in the know with updates to Fisogatinib in Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page.